CLEVELAND & ATLANTA--(BUSINESS WIRE)--ImageIQ, an innovative Imaging Software and Contract Research Organization supporting preclinical research and clinical trials, formally announced today an MOU with T3 Labs, an Atlanta-based provider of biomedical preclinical testing and training services, to enhance and accelerate preclinical research and development through the use of quantitative imaging and image analysis. The two organizations have been successfully working together for the better part of two years.
The collaboration will combined T3 Labs’ expertise in preclinical study design and execution with ImageIQ’s unique blend of imaging expertise and software-based quantitative image analysis and data reporting. Together, the collaborators will custom-tailor their services and technology to fit to the needs of each study they support. The overarching goal of the collaboration will be to leverage quantitative imaging and image analysis to accelerate biomedical product testing, regulatory approval and commercialization through better science and stronger, more objective data.
As a result, medical device, biologic and drug companies will have access to a comprehensive single source of preclinical expertise and services spanning study design to animal husbandry to surgical procedures to multi-modal image acquisition, analysis and data reporting.
“T3 Labs is delighted to strategically align with ImageIQ,” said Dr. Evan Goldberg, T3 Labs Program Director. “Our past success with ImageIQ made this an easy decision for us to make. We are committed to being on the forefront of the changing technology and methodology paradigms in preclinical research and development, and thereby delivering sustained value to our clients by leveraging ImageIQ’s expertise and technology,” added Goldberg.
“This collaboration is strategically important to us for our preclinical research market, and we are pleased to have T3 Labs as a partner,” said Tim Kulbago, ImageIQ CEO. “Their expertise in designing and executing preclinical studies perfectly aligns with ours in preclinical imaging and image analysis, and their cultural obsession with customer service made it an ideal fit,” said Kulbago.
ImageIQ is an Imaging Contract Research Organization (ICRO) that combines software engineering with biomedical and imaging expertise to provide quantitative visual analysis that enhances R&D and product efficacy/safety testing for research, medical device and pharmaceutical organizations. Incubated within Cleveland Clinic for the better part of a decade, ImageIQ provides customized image analytics and reporting, delivering objective quantitative evidence that speeds time to discovery and market entry, reduces internal overhead and improves grant proposal attractiveness and fundability. By advancing the speed of research, ImageIQ customers can extend their expertise and abilities and complete work quickly, allowing innovative staff members to focus on creative solutions to research. www.Image-IQ.com
T3 Labs is an independently operated, privately held, non-profit 501(c)(3) organization. In 2012, T3 Labs became a wholly-owned subsidiary of a joint-operating company formed by Emory Healthcare and Saint Joseph’s Health System. The T3 Labs is comprised of over 35 full-time team members and dozens of specialized contractors. With 15 years of experience, T3 Labs’ mission remains – to provide high-value preclinical testing and training services to medical device, biologics, and pharmaceutical developers and manufacturers. T3 Labs works with industry and academic sponsors to improve patient care by more effectively and efficiently developing and commercializing their devices and products. www.t3labs.org